Lot numbers can be found on the outside label of a product:
Please log in for operation!
*For research and further manufacturing use only, not for direct human use.
Structure of 1496997-41-1
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
Thalidomide-5,6-F exhibits enhanced metabolic stability due to fluorination at the 5,6-positions, which modulates electron density across the phthalimide ring. This substitution improves resistance to oxidative degradation while preserving the compound’s ability to engage target proteins involved in angiogenesis and inflammation. The fluorinated derivative offers a robust platform for probing structure-activity relationships in immunomodulatory drug development.
Thalidomide-5,6-F serves as a fluorinated analog of thalidomide, enabling targeted exploration of structure-activity relationships in immunomodulatory and anti-angiogenic scaffolds. The 5,6-difluoro substitution enhances metabolic stability and modulates electronic properties, facilitating improved functional group tolerance in downstream conjugation reactions. Its bench-stable crystalline form simplifies handling and purification, making it suitable for use in medicinal chemistry campaigns requiring precise stereochemical control and predictable reactivity profiles.
|
GHS Pictogram :
|
GHS No : GHS07
|
|
Signal Word : Warning
|
UN#: N/A
|
|
Class : N/A
|
Packing Group : N/A
|
|
Hazard Statements : H302-H315-H319-H335
|
|
|
Precautionary Statements : P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362-P405-P501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Lot numbers can be found on the outside label of a product: